Vaxcyte, Inc. (PCVX) — DEF 14A Filings

All DEF 14A filings from Vaxcyte, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

  • Vaxcyte DEF 14A: Executive Pay & Governance Details — Apr 28, 2025 Risk: medium
    Vaxcyte, Inc. filed its DEF 14A on April 28, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024. The f
  • Vaxcyte, Inc. DEF 14A Filing — Apr 15, 2024 Risk:
    Vaxcyte, Inc. (PCVX) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. Vaxcyte, Inc. filed a DEF 14A form on April 15, 2024. The filing pertains

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.